上海百心安生物技术股份有限公司（百心安-B，股票代码：02185）于2026年5月6日发布2026年4月股份变动月报表。公告显示，报告期为截至2026年4月30日止一个月。
根据披露，公司普通股包括H股与非上市外资股两类。其中，H股共235,703,422股，非上市外资股共7,713,678股，合计243,417,100股。报告期内各类股份数量、面值及已发行股本均没有发生增减变动，也未出现任何股份回购、注销或库藏股活动。
公告指出，于期内无新的股份期权或股权激励计划情况。同时，公司确认已遵守香港联交所《上市规则》及相关法律规定，满足适用的最低公众持股量要求。该公告由执行董事兼联席公司秘书王云磬签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.